胃滞留药物输送系统外包市场 - 全球产业规模、份额、趋势、机会和预测，按剂型（片剂、液体、微球、胶囊等）区域和竞争细分，2020-2030 年

2024 年全球胃滞留药物输送系统外包市场价值为 13.7 亿美元，预计到 2030 年将达到 18.9 亿美元，预测期内复合年增长率为 5.51%。全球胃滞留药物输送系统外包市场是製药和医疗保健产业内一个充满活力且快速发展的产业。胃滞留给药系统是指使药物能够在胃中停留较长时间的专门配方和技术，从而实现控制释放和标靶治疗效果。由于对提高药物生物利用度、改善患者依从性并减少副作用的新型药物输送系统的需求不断增加，该细分市场正在经历显着增长。

胃肠道疾病等慢性疾病的发生率不断上升，需要有效且患者友善的药物传递解决方案。此外，人口老化和对先进製药技术认识的不断提高正在推动对胃滞留药物输送系统的需求。製药业越来越多地将这些系统的开发和製造外包给专门的合约研究组织（CRO）和合约製造组织（CMO），以利用他们的专业知识并缩短产品上市时间。

该市场的特点是外包服务种类繁多，包括配方开发、临床前和临床测试以及胃滞留药物输送系统的商业规模生产。 CRO 和 CMO 在提供涵盖研发、技术选择、法规遵循和品质保证的端到端解决方案方面发挥关键作用。因此，製药公司可以专注于药物发现和临床开发的核心竞争力，同时依靠外包合作伙伴来获得胃滞留药物输送的专业知识。

此外，区域扩张、策略合作以及研发活动的投资也促进了市场的快速成长。随着新型胃滞留药物传递技术的发展，市场正在经历创新的热潮，包括漂浮系统、生物黏合系统和可扩展系统。

主要市场驱动因素

胃肠道疾病盛行率上升

主要市场挑战

智慧财产权问题

主要市场趋势

靶向药物传输需求不断增长

目录

第 1 章：产品概述

第 2 章：研究方法

第 3 章：执行摘要

第四章：全球胃滞留药物输送系统外包市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 按剂型（锭剂、液体、微球、胶囊、其他）
  • 按地区
  • 按公司分类（2024）
• 市场地图
  • 按剂型
  • 按地区

第五章：亚太胃滞留药物输送系统外包市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 按剂型
  • 按国家
• 亚太地区：国家分析
  • 中国
  • 印度
  • 澳洲
  • 日本
  • 韩国

第六章：欧洲胃滞留药物输送系统外包市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 德国
  • 西班牙
  • 义大利
  • 英国

第 7 章：北美胃滞留药物输送系统外包市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 墨西哥
  • 加拿大

第 8 章：南美洲胃滞留药物输送系统外包市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 阿根廷
  • 哥伦比亚

第 9 章：中东和非洲胃滞留药物输送系统外包市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 沙乌地阿拉伯
  • 阿联酋

第 10 章：市场动态

• 驱动程式
• 挑战

第 11 章：市场趋势与发展

• 最新动态
• 产品发布
• 合併与收购

第 12 章：全球胃滞留药物输送系统外包市场：SWOT 分析

第 13 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 14 章：竞争格局

• Catalent, Inc
• Lonza Group
• Evonik Industries AG
• Colorcon
• Quotient Sciences
• AptarGroup, Inc.
• Aenova Holding GmbH
• Evotec SE
• Vectura Group Ltd
• Ashland Inc.

第 15 章：策略建议

第16章调查会社について・免责事项

Global Gastroretentive Drug Delivery Systems Outsourcing Market was valued at USD 1.37 billion in 2024 and is expected to reach USD 1.89 billion by 2030 with a CAGR of 5.51% during the forecast period. The Global Gastroretentive Drug Delivery Systems Outsourcing Market is a dynamic and rapidly evolving sector within the pharmaceutical and healthcare industry. Gastroretentive drug delivery systems refer to specialized formulations and technologies that enable drugs to be retained in the stomach for an extended period, facilitating controlled release and targeted therapeutic effects. This market segment is witnessing significant growth due to the increasing demand for novel drug delivery systems that enhance drug bioavailability, improve patient compliance, and reduce side effects.

the rising prevalence of chronic diseases, such as gastrointestinal disorders, which require effective and patient-friendly drug delivery solutions. Moreover, an aging population and increasing awareness of advanced pharmaceutical technologies are propelling the demand for gastroretentive drug delivery systems. The pharmaceutical industry is increasingly outsourcing the development and manufacturing of these systems to specialized contract research organizations (CROs) and contract manufacturing organizations (CMOs) to leverage their expertise and reduce time-to-market.

The market is characterized by a diverse range of outsourcing services, including formulation development, preclinical and clinical testing, and commercial-scale production of gastroretentive drug delivery systems. CROs and CMOs are playing a pivotal role in offering end-to-end solutions that encompass research and development, technology selection, regulatory compliance, and quality assurance. As a result, pharmaceutical companies can focus on their core competencies in drug discovery and clinical development, while relying on outsourcing partners for specialized expertise in gastroretentive drug delivery.

Furthermore, regional expansion, strategic collaborations, and investments in research and development activities are contributing to the market's rapid growth. The market is witnessing a surge in innovation, with the development of novel gastroretentive drug delivery technologies, including floating systems, bio adhesive systems, and expandable systems.

Key Market Drivers

Rising Prevalence of Gastrointestinal Disorders

The rising prevalence of gastrointestinal disorders is a pivotal driver behind the growth of the Global Gastroretentive Drug Delivery Systems Outsourcing Market. Gastrointestinal conditions, such as gastroesophageal reflux disease (GERD), irritable bowel syndrome (IBS), inflammatory bowel disease, and peptic ulcers, are becoming increasingly common worldwide. These disorders can significantly impact an individual's quality of life and managing them effectively often requires specialized pharmaceutical interventions.

According to World Gastroenterology Organisation, overall, 49% of females and 36.6% of males met criteria for at least one FGID - the most common disorders in all regions being functional constipation, functional dyspepsia, proctalgia fugax, functional diarrhea and IBS at prevalence rates of 11.7%, 7.2%, 5.9%, 4.7% and 4.1, respectively.

Gastroretentive drug delivery systems play a crucial role in addressing the challenges associated with treating gastrointestinal disorders. These innovative systems allow drugs to remain in the stomach for an extended period, ensuring localized treatment and controlled release of therapeutic agents. This approach not only enhances the bioavailability of drugs but also minimizes side effects and maximizes the effectiveness of treatment, providing much-needed relief to patients suffering from gastrointestinal ailments.

Key Market Challenges

Intellectual Property Concerns

In the competitive world of pharmaceuticals, companies invest heavily in research and development to create proprietary innovations, including gastroretentive drug delivery technologies. These innovations often form the core of their product portfolio and protecting them through IP rights is essential for maintaining a competitive edge. The fear of losing exclusive rights to these innovations can lead to hesitancy in sharing proprietary information with outsourcing partners, potentially hampering collaboration.

Collaborations between pharmaceutical companies and contract research organizations (CROs) or contract manufacturing organizations (CMOs) require a degree of information exchange. For the successful development and manufacturing of gastroretentive drug delivery systems, there's a need to share critical data, formulation knowledge, and technical expertise. However, striking the right balance between knowledge sharing and IP protection can be challenging. Pharmaceutical companies must carefully manage their IP while ensuring that their outsourcing partners have the necessary information to deliver high-quality products.

Key Market Trends

Increasing Demand for Targeted Drug Delivery

The Global Gastroretentive Drug Delivery Systems Outsourcing Market is experiencing a significant boost due to the increasing demand for targeted drug delivery solutions. This surge in demand is fueled by several factors and represents a key driving force shaping the future of the pharmaceutical outsourcing industry.

One of the most prominent factors driving the increasing demand for targeted drug delivery is the growing recognition of the limitations of traditional drug delivery methods. Conventional oral drug delivery often lacks specificity, with drugs being absorbed throughout the gastrointestinal tract. This can lead to reduced drug bioavailability and increased side effects, making it less than ideal for many therapeutic applications.

gastroretentive drug delivery systems offer a highly effective means of targeting specific regions within the gastrointestinal tract, particularly the stomach. These systems allow drugs to remain in the stomach for an extended duration, ensuring that they are delivered precisely where they are needed. This localized, site-specific approach not only enhances drug bioavailability but also minimizes unwanted side effects, improving the overall therapeutic outcomes for patients.

Key Market Players

• Catalent, Inc
• Lonza Group
• Evonik Industries AG
• Colorcon
• Quotient Sciences
• AptarGroup, Inc.
• Aenova Holding GmbH
• Evotec SE
• Vectura Group Ltd
• Ashland Inc.

Report Scope:

In this report, the Global Gastroretentive Drug Delivery Systems Outsourcing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Gastroretentive Drug Delivery Systems Outsourcing Market, By Dosage Form:

• Tablets
• Liquid
• Microspheres
• Capsule
• Others

Gastroretentive Drug Delivery Systems Outsourcing Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Gastroretentive Drug Delivery Systems Outsourcing Market.

Available Customizations:

Global Gastroretentive Drug Delivery Systems Outsourcing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Gastroretentive Drug Delivery Systems Outsourcing Market Outlook

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
• 4.2. Market Share & Forecast
  • 4.2.1. By Dosage Form(Tablets, Liquid, Microspheres, Capsule, Others)
  • 4.2.2. By Region
  • 4.2.3. By Company (2024)
• 4.3. Market Map
  • 4.3.1. By Dosage Form
  • 4.3.2. By Region

5. Asia Pacific Gastroretentive Drug Delivery Systems Outsourcing Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Dosage Form
  • 5.2.2. By Country
• 5.3. Asia Pacific: Country Analysis
  • 5.3.1. China Gastroretentive Drug Delivery Systems Outsourcing Market Outlook
    • 5.3.1.1. Market Size & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share & Forecast
      • 5.3.1.2.1. By Dosage Form
  • 5.3.2. India Gastroretentive Drug Delivery Systems Outsourcing Market Outlook
    • 5.3.2.1. Market Size & Forecast
      • 5.3.2.1.1. By Value
    • 5.3.2.2. Market Share & Forecast
      • 5.3.2.2.1. By Dosage Form
  • 5.3.3. Australia Gastroretentive Drug Delivery Systems Outsourcing Market Outlook
    • 5.3.3.1. Market Size & Forecast
      • 5.3.3.1.1. By Value
    • 5.3.3.2. Market Share & Forecast
      • 5.3.3.2.1. By Dosage Form
  • 5.3.4. Japan Gastroretentive Drug Delivery Systems Outsourcing Market Outlook
    • 5.3.4.1. Market Size & Forecast
      • 5.3.4.1.1. By Value
    • 5.3.4.2. Market Share & Forecast
      • 5.3.4.2.1. By Dosage Form
  • 5.3.5. South Korea Gastroretentive Drug Delivery Systems Outsourcing Market Outlook
    • 5.3.5.1. Market Size & Forecast
      • 5.3.5.1.1. By Value
    • 5.3.5.2. Market Share & Forecast
      • 5.3.5.2.1. By Dosage Form

6. Europe Gastroretentive Drug Delivery Systems Outsourcing Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Dosage Form
  • 6.2.2. By Country
• 6.3. Europe: Country Analysis
  • 6.3.1. France Gastroretentive Drug Delivery Systems Outsourcing Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Dosage Form
  • 6.3.2. Germany Gastroretentive Drug Delivery Systems Outsourcing Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Dosage Form
  • 6.3.3. Spain Gastroretentive Drug Delivery Systems Outsourcing Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Dosage Form
  • 6.3.4. Italy Gastroretentive Drug Delivery Systems Outsourcing Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Dosage Form
  • 6.3.5. United Kingdom Gastroretentive Drug Delivery Systems Outsourcing Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Dosage Form

7. North America Gastroretentive Drug Delivery Systems Outsourcing Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Dosage Form
  • 7.2.2. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Gastroretentive Drug Delivery Systems Outsourcing Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Dosage Form
  • 7.3.2. Mexico Gastroretentive Drug Delivery Systems Outsourcing Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Dosage Form
  • 7.3.3. Canada Gastroretentive Drug Delivery Systems Outsourcing Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Dosage Form

8. South America Gastroretentive Drug Delivery Systems Outsourcing Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Dosage Form
  • 8.2.2. By Country
• 8.3. South America: Country Analysis
  • 8.3.1. Brazil Gastroretentive Drug Delivery Systems Outsourcing Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Dosage Form
  • 8.3.2. Argentina Gastroretentive Drug Delivery Systems Outsourcing Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Dosage Form
  • 8.3.3. Colombia Gastroretentive Drug Delivery Systems Outsourcing Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Dosage Form

9. Middle East and Africa Gastroretentive Drug Delivery Systems Outsourcing Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Dosage Form
  • 9.2.2. By Country
• 9.3. MEA: Country Analysis
  • 9.3.1. South Africa Gastroretentive Drug Delivery Systems Outsourcing Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Dosage Form
  • 9.3.2. Saudi Arabia Gastroretentive Drug Delivery Systems Outsourcing Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Dosage Form
  • 9.3.3. UAE Gastroretentive Drug Delivery Systems Outsourcing Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Dosage Form

10. Market Dynamics

• 10.1. Drivers
• 10.2. Challenges

11. Market Trends & Developments

• 11.1. Recent Developments
• 11.2. Product Launches
• 11.3. Mergers & Acquisitions

12. Global Gastroretentive Drug Delivery Systems Outsourcing Market: SWOT Analysis

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Product

14. Competitive Landscape

• 14.1. Catalent, Inc
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Current Capacity Analysis
  • 14.1.5. Financials (In case of listed)
  • 14.1.6. Recent Developments
  • 14.1.7. SWOT Analysis
• 14.2. Lonza Group
• 14.3. Evonik Industries AG
• 14.4. Colorcon
• 14.5. Quotient Sciences
• 14.6. AptarGroup, Inc.
• 14.7. Aenova Holding GmbH
• 14.8. Evotec SE
• 14.9. Vectura Group Ltd
• 14.10.Ashland Inc.

15. Strategic Recommendations

16. About Us & Disclaimer